A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect
- 1 July 2005
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (13) , 5481-5484
- https://doi.org/10.1158/0008-5472.can-05-0825
Abstract
In a recent article, a candidate pathway approach was taken to try to identify single nucleotide polymorphisms (SNP) that make up the genetic variation, which underlies the phenotypic variation seen between individuals in their susceptibility to cancer and the progression of their disease. The p53 stress response pathway was chosen given its well-documented importance in tumor suppression. A SNP was found which associates with the attenuation of the p53 pathway and the acceleration of tumor formation in humans and data was presented which describe a molecular mechanism for these phenotypes.Keywords
This publication has 21 references indexed in Scilit:
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing IrradiationMolecular and Cellular Biology, 2003
- The p53–Mdm2 module and the ubiquitin systemPublished by Elsevier ,2002
- The Sequence of the Human GenomeScience, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Acknowledgement to the 2000 ReviewersAnnals of Nutrition and Metabolism, 2000
- Opposing Effects of Ras on p53: Transcriptional Activation of mdm2 and Induction of p19ARFPublished by Elsevier ,2000
- The MDM2 gene amplification databaseNucleic Acids Research, 1998
- Is p53 Polymorphism Maintained by Natural Selection?Human Heredity, 1994